The evolution of debulking nephrectomy and patient characteristics in metastatic renal cell cancer patients enrolled into first-line tyrosine kinase inhibitors clinical trials.
Avishay Sella
Consultant or Advisory Role - Bayer; GlaxoSmithKline; Novartis; Pfizer
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bayer; GlaxoSmithKline; Novartis; Pfizer
Kongming Wang
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Tal Sella
No relevant relationships to disclose